Aseel M. Al Dayyeni (2023) “The prevalence of JAK2, CALR, and MPL mutations in BCR-ABL1 rearrangement negative Iraqi patients”, Journal of Population Therapeutics and Clinical Pharmacology, 30(3), pp. 443–451. doi:10.47750/jptcp.2023.30.03.046.